A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Baylis Medical Opens MedTech Facility in Costa Rica

Baylis Medical is a Canadian company and leader in the development and commercialization of innovative medical devices in cardiology. Today the company announced its arrival in Costa Rica.

Costa Rica is committed to strengthening our productive sectors with high added value, via products and services that revolutionize the market while simultaneously generating quality formal employment – jobs with lasting roots and consistent opportunities for growth.

“With the opening of the Baylis Medical, the country, once again, focuses its trajectory for growth and innovation on the medical device industry. We are very proud that Baylis Medical has put its trust in Costa Rica to launch such an important plant, which will serve international markets through a strategic and transformative vision. We are very enthusiastic about this news and, from all of us at the Ministry of Foreign Trade, we wish Baylis Medical the greatest success,” commented Andrés Valenciano, Costa Rican Minister of Foreign Trade.

“We are proud to be expanding Baylis Medical with a new facility in Costa Rica. Our team in Costa Rica will be instrumental in helping us serve patients through leading cardiology devices that will improve the lives of people around the world for years to come,” said Kris Shah, President of Baylis Medical.

Jorge Sequeira, CINDE’s managing director, commented, “Thanks to its acknowledged track record in life sciences, the country has 12 of the world’s 30 leading medical firms. Today, Baylis Medical joins the cluster, which by the end of 2020 consisted of 81 companies and generated an accumulated total of more than 38,000 jobs in Costa Rica. Investing with purpose is taking on greater relevance for industry leaders and the country continues to lead in investment destinations noted for human talent, target market proximity, and supplier availability, based on extremely innovative concepts of sustainable production.”

Baylis Medical highlighted Costa Rica’swell-established medical device manufacturing sector, and its highly skilled workforce for its investment decision. In terms of core values, Costa Rica’s similarities to Canada made the country attractive for its expansion.

People interested in applying for one of the company’s positions may do so at costarica@baylismedical.com. The company is currently looking for a core team that will support the operation setup. It searches for passionate, energetic, and team-oriented staff. In the new year, Baylis Medical will begin building a team of manufacturing employees to support production of its world-leading cardiology devices.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy